Plain-English translation of NCT05547048 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 4 โ The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This study is testing a new way to deliver HIV prevention medication (called PrEP) and medications for opioid use disorder through video visits and phone contact, rather than requiring in-person appointments. The program is designed specifically for women involved in the criminal justice system who have opioid use disorder and are at risk for HIV. The goal is to make these life-saving treatments easier to access by bringing care directly to participants through their phones or computers.
Many women involved in the criminal justice system face major barriers to getting HIV prevention and opioid treatment โ including transportation challenges, scheduling conflicts, and stigma. This trial exists to see if offering this medication through virtual visits can help more women access these treatments and stay engaged in their care.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will be randomly assigned to one of two groups. One group will receive virtual care visits with a healthcare provider using video, phone, or text to receive both HIV prevention medication and opioid treatment medications, along with a personalized decision-making tool. The other group will receive the decision-making tool and referrals to community clinics for care. Either way, you'll have follow-up check-ins at 1 month, 3 months, and 6 months to see how you're doing.
AI-generated summary from trial data ยท Jun 14, 2026 ยท Not medical advice
United States